This review aims to demonstrate how the BCR, specific signaling pathways like PI3K/AKT/mTOR, NF-kB, and JAK/STAT are diverse in common types of B-cell lymphoma. This evidence concerns the gene NFKB1 and B-cell non-Hodgkin lymphoma.